Convergent synthesis of potent COX-2 inhibitor inotilone

Tetrahedron Letters

Volumn 48, Issue 22, 2007, Pages 3767-3769

  Shamshina, Julia L ^a   Snowden, Timothy S ^a  

^a UNIVERSITY OF ALABAMA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLACETONE; BIS(SILYL ENOL ETHER); CYCLOOXYGENASE 2 INHIBITOR; ETHER DERIVATIVE; I BROMO 2,4 PENTANEDIONE; INOTILONE; UNCLASSIFIED DRUG;

ARTICLE; DEHYDRATION; DRUG POTENCY; DRUG SYNTHESIS; MUKAIYAMA REACTION;

EID: 34247615999     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2007.03.166     Document Type: Article

References (21)

1. For select reviews see:. Samoha S., and Arber N. Oncology 69 (2005) 33-37
2. Arber N., Eagle C.J., Spicak J., Rasz I., Petr D., Jan H., Zavoral M., Lechuga M.J., Gerletti P., Tang J., Rosenstein R.B., Macdonald K., Bhadra P., Fowler R., Wittes J., Zauber A.G., Solomon S.D., and Levin B. N. Eng. J. Med. 355 (2006) 2371-2373
3. Sinicrope F.A. Mol. Carcinogen. 45 (2006) 447-454
4. Bundred N.J., and Barnes N.L.P. Brit. J. Cancer 93 (2005) 510-515
5. Uray I.P., and Brown P.H. Expert Opin. Inv. Drug. 15 (2006) 1583-1600
6. For a review see:. Chinthalapally V.R., and Reddy B.S. Curr. Cancer Drug Tar. 4 (2004) 29-42
7. Choy H., and Milas L. J. Natl. Cancer Inst. 95 (2003) 1440-1452
8. Nakata E., Mason K.A., Hunter N., Husain A., Raju U., Zhongxing L., Kian K.A., and Luka M. Int. J. Radiat. Oncol. 58 (2004) 369-375
9. McGeer E.G., and McGeer P.L. Biodrugs 19 (2005) 31-37
10. Jingjing Z., Ding E.L., and Yiqing S. J. Am. Med. Assoc. 296 (2006) 1619-1632
11. McGettigan P., and Henry D. J. Am. Med. Assoc. 296 (2006) 1633-1644
12. Grösch S., Maier T.J., Schiffman S., and Geisslinger G. J. Natl. Cancer Inst. 98 (2006) 736-747
13. Gerardo E., and Schwarz E.R. J. Am. Coll. Cardiol. 49 (2007) 1-14
14. Wangun H.V.K., Härtl A., Kiet T.T., and Hertweck C. Org. Biomol. Chem. 4 (2006) 2545-2548
15. Vane J.R., Bakhle Y.S., and Botting R.M. Annu. Rev. Pharmacol. Toxicol. 38 (1998) 97-120
16. Chan C.-C., Boyce S., Brideau C., Charleson S., Cromlish W., Ethier D., Evans J., Ford-Hutchinson A.W., Forrest M.J., Gauthier J.Y., Gordon R., Gresser M., Guay J., Kargman S., Kennedy B., Leblanc Y., Leger S., Mancini G., O'Neill G.P., Ouellet M., Patrick D., Percival M.D., Perrier H., Prasit P., Rodger I.W., Tagari P., Therien M., Vickers P., Visco D., Wang Z., Webb J., Wong E., Xu L.-J., Young R.N., Zamboni R., and Riendau D. J. Pharmacol. Exp. Ther. 290 (1999) 551-560
17. Winkler J.D., Oh K., and Asselin S.M. Org. Lett. 7 (2005) 387-389
18. Cui J.-N., Teraoka R., Ema T., Sakai T., and Utaka M. Tetrahedron Lett. 38 (1997) 3021-3024
19. Magen S., Oren J., and Fuchs B. Tetrahedron Lett. 25 (1984) 3369-3372
20. Kumler W.D. J. Am. Chem. Soc. 60 (1938) 855-856
21. Molander G.A., and Cameron K.O. J. Am. Chem. Soc. 115 (1993) 830-846